無針ドラッグデリバリー機器市場規模、シェア、成長分析：タイプ別、用途別、地域別 - 産業予測 2025～2032年

無針ドラッグデリバリー機器市場規模は2023年に141億米ドルと評価され、2024年の150億7,000万米ドルから2032年には257億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.9％で成長する見通しです。

無針ドラッグデリバリー機器の世界市場は、従来の注射針による薬剤投与に代わる選択肢を提供することで、ヘルスケア業界に革命を起こす準備が整っています。この市場は、特に自己免疫疾患や糖尿病などの慢性疾患に対する、痛みのない患者中心のソリューションに対する需要の高まりによって、大きな成長を遂げています。経皮パッチやジェット注射器などのイノベーションは、精度と使いやすさを提供することで市場の魅力を高めています。現在はヘルスケア施設での使用が主流だが、在宅ケアの現場でも急速に人気が高まっています。吸入式システムのような最先端技術の急増は、業界が患者の快適性を重視していることを裏付けています。しかし、高い開発コストや規制上のハードルといった課題は、成長を制限する可能性があります。全体として、ヘルスケアにおける継続的な進化は、針を使わないドラッグデリバリーソリューションの有望な未来を示唆しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術分析
• 特許分析

無針ドラッグデリバリー機器市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 吸入器技術
• 経皮パッチ技術
• 新しい針なし技術

無針ドラッグデリバリー機器市場規模：用途別& CAGR（2025-2032）

• 市場概要
• ワクチンの配送
• 疼痛管理
• 糖尿病に対するインスリン投与
• 小児用注射
• その他

無針ドラッグデリバリー機器市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• PenJet（USA）
• Zealand Pharma（Denmark）
• UCB S.A.（Belgium）
• PharmaJet（USA）
• 3M（USA）
• Verdict Media Limited（UK）
• INJEX Pharma AG（Germany）
• Antares Pharma（USA）
• Endo Pharmaceuticals Inc.（USA）
• Bioject Medical Technologies, Inc.（USA）
• Crossject SA（France）
• MannKind Corporation（USA）
• Mika Medical Co.（South Korea）
• Halozyme, Inc.（USA）
• Akra Dermojet（Turkey）
• Zydus Group（India）
• Ferring B.V.（Switzerland）
• Gerresheimer AG（Germany）
• AptarGroup, Inc.（USA）
• MIIST Therapeutics（USA）

結論と提言

Needle-free Drug Delivery Devices Market size was valued at USD 14.1 billion in 2023 and is poised to grow from USD 15.07 billion in 2024 to USD 25.71 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global needle-free drug delivery devices market is poised to revolutionize the healthcare industry by offering alternatives to traditional needle-based drug administration. This market has witnessed significant growth, driven by the increasing demand for pain-free, patient-centric solutions, particularly for chronic conditions like autoimmune disorders and diabetes. Innovations like transdermal patches and jet injectors are enhancing market appeal by providing precision and ease of use. While healthcare facilities currently dominate usage, homecare settings are rapidly gaining popularity. The surge of cutting-edge technologies, such as inhalable systems, underscores the industry's focus on patient comfort. However, challenges like high development costs and regulatory hurdles could limit growth. Overall, the ongoing evolution in healthcare signals a promising future for needle-free drug delivery solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Needle-Free Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Needle-Free Drug Delivery Devices Market Segments Analysis

Global Needle-free Drug Delivery Devices Market is segmented by Type, Application and region. Based on Type, the market is segmented into Inhaler technology, Transdermal patch technology and Novel needle-free technologies. Based on Application, the market is segmented into Vaccine delivery, Pain management, Insulin delivery for diabetes, Pediatric injections and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Needle-Free Drug Delivery Devices Market

The Needle-Free Drug Delivery Devices market is thriving due to the advent of innovative devices that offer enhanced efficiency and precision. Continuous advancements in needle-free technology have paved the way for the emergence of sophisticated solutions such as transdermal patches, micro-needles, and jet injectors. These cutting-edge devices cater to a wide range of medical applications, capitalizing on the growing trend towards more effective and less invasive drug administration methods. As technology evolves, these delivery systems are not only becoming increasingly accurate but also adaptable to diverse therapeutic needs, positioning the market for substantial growth and transformation.

Restraints in the Needle-Free Drug Delivery Devices Market

The needle-free drug delivery devices market faces significant challenges due to stringent regulatory oversight within the medical device industry. The approval process for these innovative products can be lengthy and complex, creating obstacles for manufacturers. While these regulations are essential for ensuring patient safety and the effectiveness of injections, they also present hurdles that can lead to increased development costs and delays in production and distribution. As companies navigate the intricate landscape of regulatory compliance, the associated timeframes and financial implications can hinder the advancement and commercialization of needle-free drug delivery technologies.

Market Trends of the Needle-Free Drug Delivery Devices Market

The Needle-Free Drug Delivery Devices market is experiencing a dynamic shift as expanding applications in healthcare broaden its scope beyond traditional uses such as insulin and vaccines. The surge in interest in these devices over the past few years can be attributed to technological advancements that enable their application in specialized therapeutics and biologics, enhancing their versatility and appeal. As the demand for precise and controlled drug administration continues to rise alongside a move towards patient-centric care, the market is poised for further innovations and a diversification of uses, driving growth and evolution in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis
• Patent Analysis

Global Needle-free Drug Delivery Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Inhaler technology
• Transdermal patch technology
• Novel needle-free technologies

Global Needle-free Drug Delivery Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Vaccine delivery
• Pain management
• Insulin delivery for diabetes
• Pediatric injections
• Others

Global Needle-free Drug Delivery Devices Market Size & CAGR (2025-2032)

• North America (Type, Application)
  • US
  • Canada
• Europe (Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• PenJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zealand Pharma (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCB S.A. (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verdict Media Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INJEX Pharma AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antares Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crossject SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MannKind Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mika Medical Co. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Halozyme, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akra Dermojet (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring B.V. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MIIST Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations